Clinical Features of Graves' Ophthalmopathy in an Incidence Cohort

Bartley, 1995, The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota, Am J Ophthalmol, 120, 511, 10.1016/S0002-9394(14)72666-2 Bartley, 1996, The treatment of Graves' ophthalmopathy in an incidence cohort, Am J Ophthalmol, 121, 200, 10.1016/S0002-9394(14)70585-9 Bartley, 1995, Diagnostic criteria for Graves' ophthalmopathy, Am J Ophthalmol, 119, 792, 10.1016/S0002-9394(14)72787-4 Stellwag, 1869, Ueber gewisse Innervationsstörungen bei der Basedow'schen Krankheit, Wien Med Wochenschr, 19, 737 Pochin, 1937, Unilateral retraction of the upper lid in Graves' disease, Clin Sci, 3, 197 Eden, 1942, Lid-retraction in toxic diffuse goitre, Lancet, 2, 385, 10.1016/S0140-6736(00)41224-9 Hales, 1960, Ocular changes in Graves' disease: a long-term follow-up study, Q J Med, 29, 113 Hodes, 1979, Thyroid ocular myopathy, Trans Am Ophthalmol Soc, 77, 80 Grove, 1981, Upper eyelid retraction and Graves' disease, Ophthalmology, 88, 499, 10.1016/S0161-6420(81)34991-4 Ohnishi, 1993, Levator palpebrae superioris muscle: MR evaluation of enlargement as a cause of upper eyelid retraction in Graves disease, Radiology, 188, 115, 10.1148/radiology.188.1.8511284 Moore, 1920, A note on the exophthalmos and limitation of the eye movements of Graves's disease, Lancet, 2, 701 Rundle, 1945, The orbital tissues in thyrotoxicosis: a quantitative analysis relating to exophthalmos, Clin Sci, 5, 51 Trokel, 1981, Correlation of CT scanning and pathologic features of ophthalmic Graves' disease, Ophthalmology, 88, 553, 10.1016/S0161-6420(81)34993-8 Forbes, 1983, Computer analysis of orbital fat and muscle volumes in Graves ophthalmopathy, AJNR Am J Neuroradiol, 4, 737 Forbes, 1986, Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle, AJNR Am J Neuroradiol, 7, 651 Drescher, 1950, Asymmetric exophthalmos, Arch Ophthalmol, 44, 109, 10.1001/archopht.1950.00910020112007 Schultz, 1961, Asymmetric proptosis, Am J Ophthalmol, 52, 10, 10.1016/0002-9394(61)90445-7 Pohjola, 1964, Unilateral exophthalmos: with special reference to endocrine exophthalmos and pseudotumor, Acta Ophthalmol, 42, 456, 10.1111/j.1755-3768.1964.tb03638.x Grove, 1975, Evaluation of exophthalmos, N Engl J Med, 292, 1005, 10.1056/NEJM197505082921905 Feldon, 1990, Diagnostic tests and clinical techniques in the evaluation of Graves' ophthalmopathy, 79 Sattler, 1909, Basedow'sche Krankheit, Volume 9, 38 Havard, 1972, Endocrine exophthalmos, Br Med J, 1, 360, 10.1136/bmj.1.5796.360 Gamblin, 1983, Prevalence of increased intraocular pressure in Graves' disease: evidence of frequent subclinical ophthalmopathy, N Engl J Med, 308, 420, 10.1056/NEJM198302243080803 Frueh, 1985, Positional effects on exophthalmometer readings in Graves' eye disease, Arch Ophthalmol, 103, 1355, 10.1001/archopht.1985.01050090107043 Petersen, 1990, Prognostic factors in the radiotherapy of Graves' ophthalmopathy, Int J Radiat Oncol Biol Phys, 19, 259, 10.1016/0360-3016(90)90532-O Pigeon, 1987, High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy, Horm Res, 26, 172, 10.1159/000180697 Pinchera, 1987, Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy, Horm Res, 26, 177, 10.1159/000180698 Kao, 1993, Radiotherapy in the management of thyroid orbitopathy: computed tomography and clinical outcomes, Arch Ophthalmol, 111, 819, 10.1001/archopht.1993.01090060107032 Bartley, 1994, The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota, Trans Am Ophthalmol Soc, 92, 477 Streeten, 1987, Prevalence, natural history and surgical treatment of exophthalmos, Clin Endocrinol, 27, 125, 10.1111/j.1365-2265.1987.tb00848.x Morris, 1988, Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods, Mayo Clin Proc, 63, 707, 10.1016/S0025-6196(12)65533-5 Kriss, 1964, Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema, J Clin Endocrinol, 24, 1005, 10.1210/jcem-24-10-1005 Gorman, 1972, Unusual manifestations of Graves' disease, Mayo Clin Proc, 47, 926 Smith, 1989, Connective tissue, glycosaminoglycans, and diseases of the thyroid, Endocr Rev, 10, 366, 10.1210/edrv-10-3-366 Fatourechi, 1994, Dermopathy of Graves disease (pretibial myxedema): review of 150 cases, Medicine, 73, 1, 10.1097/00005792-199401000-00001 Fatourechi, 1993, Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema, J Endocrinol Invest, 16, 433, 10.1007/BF03348875 Thomas, 1933, Acropachy: secondary subperiosteal new bone formation, Arch Intern Med, 51, 571, 10.1001/archinte.1933.00150230086003 Peard, 1961, Lymphadenoid goitre with hypothyroidism, exophthalmos, pretibial myxoedema and acropachy, Proc R Soc Med, 54, 342 Cushing, 1937, “Club fingers” and hypertrophic pulmonary osteoarthropathy, Int Clin, 2, 200 Rynearson, 1941, Hypertrophic pulmonary osteoarthropathy (acropachy) afflicting a patient who had postoperative myxedema and progressive exophthalmos, Proc Staff Meet Mayo Clin, 16, 353 Greene, 1951, Thyroid acropachy, Proc R Soc Med, 44, 159 Danforth, 1958, Hypertrophic osteoarthropathy and pretibial myxedema associated with Graves' disease, J Clin Endocrinol Metab, 18, 1302, 10.1210/jcem-18-11-1302 Gimlette, 1960, Thyroid acropachy, Lancet, 1, 22, 10.1016/S0140-6736(60)92719-7 Melton, 1983, Sources of disparity in the spectrum of diabetes mellitus at incidence and prevalence, Diabetes Care, 6, 427, 10.2337/diacare.6.5.427 Mulvany, 1944, The exophthalmos of hyperthyroidism: a differentiation in the mechanism, pathology, symptomatology, and treatment of two varieties, Part I, Am J Ophthalmol, 27, 589, 10.1016/S0002-9394(44)91514-X Mulvany, 1944, The exophthalmos of hyperthyroidism: a differentiation in the mechanism, pathology, symptomatology, and treatment of two varieties, Part III, Am J Ophthalmol, 27, 820, 10.1016/S0002-9394(44)91274-2 Meyerstein, 1904, Ueber das combinirte Vorkommen von Myasthenie und Basedow'scher Krankheit, Neurol Centralbl, 1089 Rennie, 1908, Exophthalmic goitre combined with myasthenia gravis, Rev Neurol Psychiatry, 6, 229 Collier, 1927, Nuclear ophthalmoplegia, with especial reference to retraction of the lids and ptosis and to lesions of the posterior commissure, Brain, 50, 488, 10.1093/brain/50.3-4.488 Millikan, 1953, The thyroid gland in relation to neuromuscular disease, Arch Intern Med, 92, 5, 10.1001/archinte.1953.00240190017002 Engel, 1961, Thyroid function and myasthenia gravis, Arch Neurol, 4, 663, 10.1001/archneur.1961.00450120077009 Johns, 1962, Involuntary eye movements in a patient with myasthenia and hyperthyroidism, Arch Ophthalmol, 67, 35, 10.1001/archopht.1962.00960020037006 Sahay, 1965, Relation between myasthenia gravis and thyroid disease, Br Med J, 1, 762, 10.1136/bmj.1.5437.762 Osserman, 1967, Myasthenia gravis and thyroid disease: clinical and immunologic correlation, Mt Sinai J Med, 34, 469 Engel, 1972, Neuromuscular manifestations of Graves' disease, Mayo Clin Proc, 47, 919 Brain, 1959, Pathogenesis and treatment of endocrine exophthalmos, Lancet, 1, 109, 10.1016/S0140-6736(59)90001-7 Furszyfer, 1970, Graves' disease in Olmsted County, Minnesota, 1935 through 1967, Mayo Clin Proc, 45, 636